Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7835509 | 0.93 | CCR5 (0.87) | CCR5 | |
| SCHEMBL7817814 | 0.92 | CCR5 (0.85) | CCR5 | |
| SCHEMBL7826200 | 0.88 | CCR5 (0.78) | CCR5 | |
| SCHEMBL8094130 | 0.84 | CCR5 (0.74) | CCR5 | |
| SCHEMBL7836855 | 0.83 | CCR5 (0.71) | CCR5 | |
| SCHEMBL7825773 | 0.79 | CCR5 (0.65) | CCR5 | |
| SCHEMBL7828983 | 0.78 | CCR5 (0.63) | CCR5 | |
| SCHEMBL7833941 | 0.76 | CCR5 (0.67) | CCR5 | |
| SCHEMBL12592397 | 0.75 | CCR5 (1.00) | CCR5 | |
| SCHEMBL7836524 | 0.75 | CCR5 (1.00) | CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1009405-A4 | PYRROLIDINE AND PIPERIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | MERCK & CO INC (US) | 2001-05-09 | — | — | EP | disclosed |
| US-6166037-A | Pyrrolidine and piperidine modulators of chemokine receptor activity | MERCK & CO., INC. (US) | 2000-12-26 | — | — | US | disclosed |
| EP-1009405-A1 | PYRROLIDINE AND PIPERIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Merck & Co., Inc. (US) | 2000-06-21 | — | — | EP | disclosed |
| WO-1999009984-A1 | PYRROLIDINE AND PIPERIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | MERCK & CO., INC. (US) | 1999-03-04 | — | — | WO | disclosed |